enGene Therapeutics Inc. (NASDAQ:ENGN) Cap table
Cap table
Built by 6ix from enGene Therapeutics Inc.’s releases · as of Nov 12, 2025
- Common shares
- 67,016,316
- Fully diluted
- 67,466,316
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 67,016,316 |
| Options and RSUs | 450,000 |
Warrants and options
| Lot |
|---|
| Stock options · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 67,016,316 |